Filtern
Erscheinungsjahr
- 2018 (2) (entfernen)
Dokumenttyp
- Posterpräsentation (2) (entfernen)
Sprache
- Englisch (2)
Referierte Publikation
- nein (2)
Schlagworte
- Fluorescence standards (1)
- Nanogenotoxicity (1)
- Qdots (1)
- Quantification (1)
- Reference materials (1)
- Surface functions (1)
Organisationseinheit der BAM
The overall interest in nanotoxicity, triggered by the increasing use of nanomaterials in the material and life sciences, and the synthesis of an ever increasing number of new functional nanoparticles calls for standardized test procedures and for efficient approaches to screen the potential genotoxicity of these materials. Aiming at the development of fast and easy to use, automated microscopic methods for the determination of the genotoxicity of different types of nanoparticles, we assess the potential of the fluorometric γH2AX assay for this purpose. This assay, which can be run on an automated microscopic detection system, relies on the detection of DNA double strand breaks (DSB) as a sign for genotoxicity. Here, we provide first results obtained with broadly used nanomaterials like CdSe/CdS and InP/ZnS quantum dots as well as iron oxide, gold, and polymer particles of different surface chemistry with previously tested colloidal stability and different cell lines like Hep-2 and 8E11 cells, which reveal a dependence of the genotoxicity on the chemical composition as well as the surface chemistry of these nanomaterials. These studies will be also used to establish nanomaterials as positive and negative genotoxicity controls or standards for assay performance validation for users of this fluorometric genotoxicity assay. In the future, after proper validation, this microscopic platform technology will be expanded to other typical toxicity assays.
Luminescence techniques are amongst the most commonly used analytical methods in life and material sciences due to their high sensitivity, nondestructive character, and easy instrumentation suitable for miniaturization. Photoluminescence signals are, however, affected by wavelength-, polarization-, and time-dependent instrument-related effects. Thus, at the core of standardization approaches for all fluorescence-based techniques are evaluated fluorescence standards for the consideration of instrument-specific spectral and intensity distortions of measured signals and for instrument performance validation (IPV).
Here, we summarize the research of BAM division 1.2 on development of liquid and solid fluorescence standards for various application-relevant fluorescence parameters and techniques. The portfolio of BAM fluorescence reference materials presently consists of:
i) a Spectral Fluorescence Standard Kit, i.e., a set of liquid fluorescence standards with certified normalized corrected emission spectra, for the determination of a broad variety of fluorescence parameters
ii) a ready-to-use, glass-based multi-emitter fluorescence standard for IPV and the determination of instrument-to-instrument variations
iii) specially adapted calibration tools and validation concepts for microarray-based platforms used in molecular diagnostics and food safety control
iv) quantum yield (Φf) standards for relative determination of the key performance parameter Φf of fluorescent materials, which can be also used for the evaluation of the performance of absolute, standard-free methods utilizing integrating sphere setups or spectrometer accessories. These materials, that will eventually cover the ultraviolet, visible, and near infrared spectral region, are currently under certification.
This toolbox of method-adapted reference materials can perfectly complement existing fluorescence standards. These easy-to-use, reference materials can pave the way to traceable fluorescence measurements to a radiometric scale like the spectral radiance or spectral photon radiance for all users of fluorescence techniques in material sciences and analysis, as well as environmental monitoring and biotechnology. They are particularly useful for customers working in strongly regulated areas like medical diagnostics or pharmaceutical research, where certified standards in conjunction with validated standard operating procedures are mandatory.